<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">The next step is to provide analogous phase diagrams for secondary infected (*-i), susceptible (*-ii), primary vaccinated (*-iii), and secondary vaccinated (*-iv) individuals against a S-4 according to variable infection rates (a-*) 
 <inline-formula>
  <math id="M210" altimg="si39.svg">
   <mrow>
    <mi>β</mi>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0.2</mn>
   </mrow>
  </math>
 </inline-formula>, (b-*) 
 <inline-formula>
  <math id="M211" altimg="si40.svg">
   <mrow>
    <mi>β</mi>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0.4</mn>
    <mo>,</mo>
   </mrow>
  </math>
 </inline-formula> and (c-*) 
 <inline-formula>
  <math id="M212" altimg="si41.svg">
   <mrow>
    <mi>β</mi>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0.8</mn>
   </mrow>
  </math>
 </inline-formula> (see 
 <xref rid="f0035" ref-type="fig">Fig. 7</xref> ). In doing so, the assumption of a low-cost vaccine is made for both costs 
 <inline-formula>
  <math id="M213" altimg="si136.svg">
   <mrow>
    <mo stretchy="false">(</mo>
    <msub>
     <mi>C</mi>
     <mi>p</mi>
    </msub>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <msub>
     <mi>C</mi>
     <mi>s</mi>
    </msub>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0.1</mn>
    <mo stretchy="false">)</mo>
   </mrow>
  </math>
 </inline-formula> introduced above, in a case where both vaccinations are equally emphasized by the public health authority. It is worth noting that the dotted triangles for the weaker infection rate (
 <inline-formula>
  <math id="M214" altimg="si39.svg">
   <mrow>
    <mi>β</mi>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0.2</mn>
   </mrow>
  </math>
 </inline-formula>) display higher susceptibility but lower secondary infection, despite relatively lower coverage for both vaccinations. Referring to existing studies (
 <xref rid="b0125" ref-type="bibr">Tanimoto, 2015</xref>, 
 <xref rid="b0130" ref-type="bibr">Tanimoto, 2019</xref>, 
 <xref rid="b0135" ref-type="bibr">Kabir et al., 2019a</xref>), this indicates that ‘free-riding’ on the so-called ‘herd immunity’ does occur, as a high efficiency for both vaccinations and relatively weaker infection rate only requires limited vaccination coverage within a society in order to stop the disease from spreading. This allows for a reasonable percentage of free-riders (no vaccination) to be present in the society.
</p>
